BIRC5 and neoplasm: Yet, re-transplanted U251-MGmycN/Survivin tumor cells with co-expression of Survivin and mycN still showed significant decreased tumor latency than re-transplanted U251-MGmycN/C tumor cells expressing mycN transgene alone.